14: Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole, metronidazole, tinidazole and clindamycin

May 2, 2017 by in GYNECOLOGY Comments Off on 14: Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole, metronidazole, tinidazole and clindamycin

Objectives Secnidazole, a 5-nitroimidazole with a longer half-life, is structurally related to metronidazole and tinidazole. For treatment of bacterial vaginosis (BV), secnidazole is a suitable single-dose oral drug having a…

read more

12: Incidence and risk factors for catheter-associated urinary tract infection (CAUTI) after cesarean delivery

May 2, 2017 by in GYNECOLOGY Comments Off on 12: Incidence and risk factors for catheter-associated urinary tract infection (CAUTI) after cesarean delivery

Objectives Cesarean delivery (CD) rates have risen steadily and until recently, the traditional surgical dogma of indwelling urethral catheters prior to CD was standard practice. While recent evidence suggests that…

read more

11: Gonorrhea, chlamydia, and trichomonas and criminal justice involvement among drug-using women in oakland, california

May 2, 2017 by in GYNECOLOGY Comments Off on 11: Gonorrhea, chlamydia, and trichomonas and criminal justice involvement among drug-using women in oakland, california

Objectives Involvement in the criminal justice system has been associated with increased rates of sexually-transmitted diseases (STDs) and HIV at the individual and community levels. Studies of testing within jails…

read more

17: Time-kill kinetics of the novel echinocandin CD101 for azole-susceptible and -resistant Candidaspp. at pH 4 in vagina-simulative medium

May 2, 2017 by in GYNECOLOGY Comments Off on 17: Time-kill kinetics of the novel echinocandin CD101 for azole-susceptible and -resistant Candidaspp. at pH 4 in vagina-simulative medium

Objectives The echinocandin class of antifungal agents has not been considered for treatment of vulvovaginal candidiasis (VVC) because currently available echinocandins are limited to IV administration. This study investigated the…

read more

7: CD101 Gel formulation is highly efficacious against azole-resistant Candida albicansin a rat model of vulvovaginal candidiasis

May 2, 2017 by in GYNECOLOGY Comments Off on 7: CD101 Gel formulation is highly efficacious against azole-resistant Candida albicansin a rat model of vulvovaginal candidiasis

Objectives The efficacy of intravaginally (IVG) administered CD101, a novel, long-acting and highly stable echinocandin formulated as a gel, was compared to marketed miconazole (MCZ) and nystatin (NYS) creams and…

read more
Get Clinical Tree app for offline access